Revvity 6 mai 2026 Revvity tops Q1 estimates and unveils plans to exit China immunodiagnostics - Indian Pharma Post
Revvity 5 mai 2026 Revvity Outperforms in Q1 2026 Driven by Pharma Rebound and Strategic Portfolio Shifts - Lab Manager
Revvity 20 avr. 2026 A Look At Revvity (RVTY) Valuation As Mixed Recent Returns Contrast With Undervaluation Narrative - Yahoo Finance
Revvity 19 avr. 2026 The Bull Case For Revvity (RVTY) Could Change Following Its New AI-Enabled Oncology Platform Push - simplywall.st
Revvity 17 avr. 2026 Revvity Showcases Integrated Cancer Research Solutions at AACR Annual Meeting 2026 - BioSpace
Revvity 9 avr. 2026 Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows - Business Wire
Revvity 13 janv. 2026 Revvity Stock Jumps on Profit Outlook Hike. Why the Shares Are at a Crossroads. - Barron's
Revvity 12 janv. 2026 Revvity, Lilly Expand Access to Federated AI Drug Discovery Models - Lab Manager
Revvity 2 oct. 2025 Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes - Business Wire